Education
About Us
Working with TipRanks
Follow Us
Neurotech International Ltd. (AU:NTI)
:NTI
NTI Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.08
Previous CloseN/A
Volume11.09K
Average Volume (3M)630.61K
Market Cap
AU$25.19M
Enterprise ValueAU$13.99M
Total Cash (Recent Filing)AU$5.96M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta1.14
Next Earnings
Aug 27, 2025EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.73
Shares Outstanding1,049,622,000
10 Day Avg. Volume679,133
30 Day Avg. Volume630,614
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)3.39
Price to Sales (P/S)0.00
P/FCF Ratio-2.03
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Neurotech International News
PremiumCompany Announcements
Neurotech International Relocates Headquarters to Melbourne
PremiumCompany Announcements
Maybank Securities Becomes Substantial Holder in Neurotech InternationalPremiumCompany Announcements
Neurotech’s Rett Syndrome Trial Results Published in Scientific Journal
PremiumCompany Announcements
Neurotech International Enhances US Presence with New Chief Medical AdvisorPremiumCompany Announcements
Neurotech’s NTI164 to be Highlighted at Rett Syndrome Scientific Meeting
PremiumCompany Announcements
Neurotech International’s NTI164 Shows Promising PK Study Results
PremiumCompany Announcements
Neurotech International Advances in Pediatric Neurological Treatments
PremiumCompany Announcements
Neurotech International Updates Trading Policy to Enhance ComplianceOptions Prices
Currently, No data available
---
Ownership Overview
0.10% Insiders
―
Mutual Funds
― Other Institutional Investors
99.90% Public Companies and
Individual Investors
NTI FAQ
What was Neurotech International Ltd.’s price range in the past 12 months?
Neurotech International Ltd. lowest share price was AU$0.01 and its highest was AU$0.08 in the past 12 months.
What is Neurotech International Ltd.’s market cap?
Neurotech International Ltd.’s market cap is AU$25.19M.
When is Neurotech International Ltd.’s upcoming earnings report date?
Neurotech International Ltd.’s upcoming earnings report date is Aug 27, 2025 which is in 28 days.
How were Neurotech International Ltd.’s earnings last quarter?
Currently, no data Available
Is Neurotech International Ltd. overvalued?
According to Wall Street analysts Neurotech International Ltd.’s price is currently Overvalued.
Does Neurotech International Ltd. pay dividends?
Neurotech International Ltd. does not currently pay dividends.
What is Neurotech International Ltd.’s EPS estimate?
Neurotech International Ltd.’s EPS estimate is >-0.01.
How many shares outstanding does Neurotech International Ltd. have?
Neurotech International Ltd. has 1,049,622,000 shares outstanding.
What happened to Neurotech International Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Neurotech International Ltd.?
Currently, no hedge funds are holding shares in AU:NTI
Neurotech International Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:NTI Sentiment 70%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-65.21%
12-Months-Change
Fundamentals
Return on Equity
-223.80%
Trailing 12-Months
Asset Growth
26.87%
Trailing 12-Months
Company Description
Neurotech International Ltd.
Neurotech International Ltd. (NTI) is a technology company specializing in the development and commercialization of medical devices and solutions designed to diagnose and treat neurological disorders. The company's core products focus on innovative applications of neurotechnology, particularly targeting conditions such as autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD). NTI is committed to advancing healthcare through cutting-edge research and development in the field of neurology.
Technical Analysis
Cann Group
―
Invex Therapeutics Ltd.
―
Althea Group Holdings Ltd.
―
Botanix Pharmaceuticals Limited
―